Recursion Pharmaceuticals, Inc.
RXRX
$4.94
$0.163.35%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.93% | -15.80% | 38.98% | -9.84% | 60.07% |
| Total Receivables | -53.16% | -6.19% | 2,080.31% | -10.73% | -2.81% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.23% | -50.39% | 59.82% | -2.72% | 1.83% |
| Total Current Assets | 0.52% | -18.22% | 50.64% | -9.23% | 52.02% |
|
|
|||||
| Total Current Assets | 0.52% | -18.22% | 50.64% | -9.23% | 52.02% |
| Net Property, Plant & Equipment | -5.46% | -12.19% | 46.50% | 1.86% | 27.87% |
| Long-term Investments | 3.89% | 6.21% | 185.99% | 0.00% | 0.00% |
| Goodwill | 3.89% | 6.21% | 185.99% | 0.00% | 0.00% |
| Total Other Intangibles | 1.65% | -0.02% | 885.11% | -10.77% | 15.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.58% | 9.90% | 134.48% | 0.75% | 0.78% |
| Total Assets | -0.22% | -9.90% | 99.39% | -6.36% | 39.08% |
|
|
|||||
| Total Accounts Payable | -23.01% | 16.07% | 856.33% | -39.93% | -26.45% |
| Total Accrued Expenses | 50.43% | -31.27% | 107.40% | 22.96% | 26.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.22% | -8.01% | 35.06% | -1.58% | 173.27% |
| Total Finance Division Other Current Liabilities | -0.13% | -34.85% | 23.10% | 50.83% | -9.73% |
| Total Other Current Liabilities | -0.13% | -34.85% | 23.10% | 50.83% | -9.73% |
| Total Current Liabilities | 15.53% | -24.27% | 72.17% | 26.49% | 16.45% |
|
|
|||||
| Total Current Liabilities | 15.53% | -24.27% | 72.17% | 26.49% | 16.45% |
| Long-Term Debt | -13.68% | 2,304.39% | -32.61% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.69% | -34.54% | 16.99% | 0.00% | 67.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.34% | 11.97% | 641.95% | -41.31% | -15.16% |
| Total Liabilities | 3.21% | -10.28% | 104.92% | 5.50% | 22.16% |
|
|
|||||
| Common Stock & APIC | 5.00% | 3.23% | 39.21% | 2.07% | 19.23% |
| Retained Earnings | -10.52% | -14.14% | -14.29% | -8.29% | -9.21% |
| Treasury Stock & Other | 208.38% | 285.22% | -- | -- | -- |
| Total Common Equity | -1.58% | -9.74% | 97.27% | -10.25% | 45.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.58% | -9.74% | 97.27% | -10.25% | 45.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.58% | -9.74% | 97.27% | -10.25% | 45.69% |
|
|
|||||